SLA and autoimmune hepatitis: Given that anti-SLA/LP autoantibodies have high specificities, and that lifetime immunosuppression is required because of a high relapse probability in anti-SLA/LP-positive AIH [34], liver biopsies and long-term follow-ups are recommended for these 12 patients.